Argon AI, a New York-based AI-native workspace purpose-built for life sciences, has raised $5.5 million in seed funding.
Investors
The round was co-led by Crosslink Capital and Wireframe Ventures, with additional participation from Y Combinator, Pioneer Fund, and other digital health and AI-focused investors.
Crosslink Capital is a San Francisco-based venture capital firm managing over $3–4 billion in assets. They invest from seed to public stages, focusing on consumer and enterprise technology, including AI, fintech, cybersecurity, and vertical SaaS.
Wireframe Ventures is a seed-stage venture capital firm founded in 2016 and based in San Francisco. They invest early primarily at the pre-seed and seed stages in startups focused on climate, health, biotech, and AI.
Argon AI Use of Funds
The company will use the funds to expand its team, enhance product capabilities, and accelerate adoption across enterprise biopharma organizations.
About Argon AI
Founded by Samy Danesh, Argon AI is building an AI-native workspace for life sciences, aiming to transform how pharmaceutical teams access and act on critical information. From competitive intelligence and knowledge management to clinical strategy and primary research, Argon helps pharma teams turn mountains of data into living dashboards and intelligent workflows. Its AI agents support use cases such as market research, competitive tracking, clinical trial benchmarking, and more. Headquartered in Brooklyn, New York, Argon is already working with top global pharmaceutical firms and leading life sciences consultancies.
Funding Details
Company: Argon AI, Inc.
Raised: $5.5M
Round: Seed
Funding Date: July 2025
Lead Investors: Crosslink Capital, Wireframe Ventures
Additional Investors: Y Combinator, Pioneer Fund, and other unnamed digital health and AI investors
Company Website: https://argon-ai.com/
Software Category: Life Sciences AI / AI-native Workspace
Source: https://www.businesswire.com/news/home/20250702864413/en/